| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +18.2K | 100% | $2.76 | +$50.4K |
| Sells | 0 | ||||
| Net | +1 | +18.2K | 100% | +$50.4K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $16.2M | Jul 1, 2022 | ||
| Jeremy M. Levin | CEO, Director | $10.1M | +$50.4K | +0.5% | Mar 18, 2024 |
| Amit Rakhit | President and CMO | $1.56M | Jul 14, 2021 | ||
| Thomas M. Perone | General Counsel, Secretary | $60.5K | Feb 22, 2024 | ||
| Jeffrey A. Rona | Cbfo | $60.5K | Jul 30, 2024 | ||
| Jason Tardio | Chief Operating Officer | $60.5K | Feb 22, 2024 | ||
| Bart Friedman | Director | Dec 12, 2024 | |||
| Karen Bernstein | Director | Dec 12, 2024 | |||
| Margaret A. Alexander | President and COO | Sep 9, 2024 | |||
| Robert Michael Poole | Director | Feb 22, 2024 | |||
| Douglas E. Williams | Director | May 17, 2021 | |||
| Kevin Joseph Fitzgerald | Director | Dec 12, 2024 | |||
| Barbara Gayle Duncan | Director | Dec 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|